Dr. Somesh Kumar’s presentation outlined Jhpiego’s experience introducing HPV testing and cervical cancer screening in LMICs, emphasizing policy, programmatic, and technological innovations. He framed efforts within WHO’s 2030 targets (90-70-90) and highlighted HPV testing as superior to VIA due to its accuracy and compatibility with self-sampling. Key innovations include decentralized services, task sharing, and integration of screening and treatment using thermal ablation and LLETZ. Lessons stressed optimizing labs, ensuring supply chains, establishing patient navigation systems, and leveraging m‑health and AI-based visual tools. Ongoing projects in India (Odisha, Uttar Pradesh, Madhya Pradesh, Sikkim) demonstrate HPV DNA testing, self-collection, and use of AI-powered scopes, aiming to align screening with broader women’s health services and scale toward elimination goals.